Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| American Well CorpAMWL · Entity 2112 | Director | June 16, 2026 | June 18, 2026 |
| Ardent Health, Inc.ARDT · Entity 4664 | Director | April 01, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
American Well Corp
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 72,559 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 14,501 · Balance 72,559 F1: Represents a grant of restricted stock units, which vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the stockholders following the grant date and (ii) the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units, which vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the stockholders following the grant date and (ii) the first anniversary of the grant date.
Ardent Health, Inc.
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,215 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 14,231 · Balance 78,215 F1: Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 21:29 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 14,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-276140 · ownership.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,559 F1 · kind: Represents a grant of restricted stock units, which vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the stockholders following the grant date and (ii) the first anniversary of the grant date. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:50 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 14,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023271 · wk-form4_1775163006.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,215 F1 · shares: Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:52 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 12,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-014759 · wk-form4_1742935943.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,984 F1 · shares: Represents restricted stock units that vest in full on the first anniversary of March 21, 2025, subject to the Reporting Person's continued service with the Issuer through the vesting date. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:17 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 10,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-051546 · wk-form4_1734387472.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,068 F1 · shares: Represents restricted stock units that vest in three substantially equal installments on each of the first, second and third anniversaries of December 12, 2024, subject to pro rata vesting if the Reporting Person's service as a director terminates under certain circumstances in connection with the Issuer's annual meeting of stockholders. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:41 UTC | Ardent Health, Inc. ARDT · Entity 4664 | PurchaseCommon Stock | 10,000 | $16.49 | $164,900.00 |
DisclosureSEC source: 0001628280-24-047644 · wk-form4_1731534108.xml · nonDerivative · entry 2 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,275 F2 · price: The price reported in Column 4 is a weighted average price of $16.49 per share. These shares were purchased in multiple transactions on 11/08/2024 at prices ranging from $16.42 to $16.51, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:41 UTC | Ardent Health, Inc. ARDT · Entity 4664 | PurchaseCommon Stock | 10,000 | $17.47 | $174,700.00 |
DisclosureSEC source: 0001628280-24-047644 · wk-form4_1731534108.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,275 F1 · price: The price reported in Column 4 is a weighted average price of $17.47 per share. These shares were purchased in multiple transactions on 11/08/2024 at prices ranging from $17.425 to $17.50, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:54 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 11,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001962 · form4.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,275 F1 · shares: Represents restricted stock units that vest in full on the first anniversary of March 31, 2024, subject to the Reporting Person's continued service with the Issuer through the vesting date. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:59 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 543,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-075693 · ownership.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743,341 F1 · shares: Represents a grant of restricted stock units, which vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the stockholders following the grant date and (ii) the first anniversary of the grant date. F2 · balance_after: Due to an administrative error, on previous filings, the reporting person inadvertently reported an incorrect total number of securities beneficially owned, which had over-included securities held by the reporting person prior to becoming an insider of the issuer. The total number has been corrected on this Form 4. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 21:13 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 91,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039756 · doc4.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,568 F1 · shares: Represents a grant of restricted stock units, which vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the stockholders following the grant date and (ii) the first anniversary of the grant date. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:09 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 107,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055359 · doc4.xml · nonDerivative · entry 1 Webb Robert Thomas · CIK 0001951658 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,825 F1 · shares: Represents a grant of restricted stock units, which vest over a three-year period from the grant date, with equal installments vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.